Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2025 STS Annual Meeting
2025 ASCO GI
2024 SABCS
Thematic Newsreels
2024 ASH Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Topics
Advertisement
Solid Tumors
Bladder Cancer
Breast Cancer
CNS Cancers
Colorectal Cancer
Gastroesophageal Cancer
Gastrointestinal Cancer
Gynecologic Cancers
Head and Neck Cancer
Hepatobiliary Cancer
Kidney Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Thyroid Cancer
Neuroendocrine Tumors
Hematologic Malignancies
Leukemia
Lymphoma
Lymphoma (Curated)
Multiple Myeloma
Myelodysplastic Syndromes
Issues in Oncology
Cardio-oncology
Cost of Care
COVID-19
Genomics/Genetics
Geriatric Oncology
Global Cancer Care
Health-Care Policy
Immunotherapy
Legislation
Survivorship
Supportive Care
Integrative Oncology
Pain Management
Palliative Care
Symptom Management
Advertisement
Advertisement
Feb
10
Today In Oncology
BOREAS Trial Navtemadlin Demonstrates Clinical Benefit in JAK Inhibitor–Refractory Myelofibrosis
New Study Identifies Potential Genes Implicated in Treatment Resistant Melanoma
Is Thyroid Cancer Overdiagnosed
Novel Personalized Cancer Vaccine May Be Effective in Patients With Stage III and IV Clear Cell Renal Cell Carcinoma
FDA Approves Preparative Regimen for Allogeneic HSCT in Patients With AML or MDS
View More
Advertisement
